Restasis purchasers win class cert
A federal judge has certified a class of indirect purchasers alleging that Allergan monopolised the market for dry-eye medication Restasis through sham petitioning to the Food and Drug Administration.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10